NEWS
CENTER

From China to the World | Genetron Health Presents at World CB&CDx Summit

Another Milestone in Genetron Health's Companion Diagnostics Service | Tazemetostat Receives Priority Review from NMPA

Publication in Cancer Letters Demonstrates Genetron Health's Seq-MRD® Superior to Multiparameter Flow Cytometry in Predicting Treatment Response and Recurrence Warning

Genetron Health Supports Denovo Biopharma Achieves Major Breakthrough in Global Clinical Trials for the First Depression Drug, First-in-class International Multi-center Pivotal Trial Reaches Clinical Endpoints

Publication in Journal for ImmunoTherapy of Cancer Demonstrates Genetron Health’s Onco-LymScan Lymphoma Genetic Test Product Helping Lymphoma Patients with Efficacy Prediction and Relapse Warning

Genetron Health’s Laboratories Achieve Perfect Scores in Over 360 Accreditations from Domestic and International Authorities for 8 Consecutive Years

For its technological and business achievements，Genetron Health was listed in Harvard Business Review's "China New Growth · Business Evolution 2023 List"

Genetron Health and AstraZeneca Jointly Launch Solid Tumor MRD Detection Product

First CDx Assay Approval in China following Bridging Path: Genetron Health's "PDGFRA D842V Mutation Detection Kit" Receives NMPA Approval

Genetron Health Releases 10 New Research Results at 2022 American Society of Clinical Oncology (ASCO) Annual Meeting

Genetron Health Receives CE Mark for Human B Lymphocyte Minimal Residual Disease Detection Kit Seq-MRD®

Genetron Health Presents 17 New Research Results at American Association for Cancer Research Annual Meeting (AACR) 2022

Publication in Clinical and Translational Medicine Demonstrates Mutation Capsule™’s potential in MRD Assay Developments

Genetron Health Announces Companion Diagnostic Collaboration Agreement with HUTCHMED’s ORPATHYS® for NSCLC

Genetron Health’s Social Contribution Campaign to Make Precision Medicine More Accessible